Quantum BioPharma: Lucid-MS Phase 1 Insights into Remyelination Therapy

© Copyright 2025 Quantum BioPharma. All Rights Reserved. Powered by ACCESS Newswire.

Investor Relations

Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
QNTM@mzgroup.us 

General Inquiries

www.quantumbiopharma.com/contact

info@quantumbiopharma.com

+1-833-571-1811

Headquarters

55 University Ave. , Suite 1003
Toronto, ON, M5J 2H7 Canada

Registered Office Address

Corporation Trust Centre
1209 Orange Street

Wilmington, Delaware, 19801, USA

Email Alerts